Rafarma Pharmaceuticals, Inc., a multi-product pharmaceutical company, produces and sells drugs, generic antibiotics, and specialty pharmaceuticals in Russia. It offers cephalosporin-based products, antibiotics of non-ß structure, and anti-cancer drugs in the form of injections, ampulla packaged products, child suspensions, tablets, and capsules. The company also provides drugs for accidental wounds, inflammatory eye diseases, and immunological disorders. The company has a collaboration agreement with PlantEXT Ltd. to research and manufacture the first medical cannabis suppositories for patients suffering from inflammatory bowel disease. Rafarma Pharmaceuticals, Inc. was formerly known as Johnston Acquisition Corp. and changed its name to Rafarma Pharmaceuticals, Inc. in October 2012. The company is based in Sandy, Utah with a manufacturing and distribution facility in Russia. As of October 19, 2020, Rafarma Pharmaceuticals, Inc. operates as a subsidiary of R. & D. Biocogency Laboratories Inc. Ltd.
Часто задаваемые вопросы
В каком секторе работает Rafarma Pharmaceuticals Inc (RAFA)?
Rafarma Pharmaceuticals Inc относится к сектору Здравоохранение.
Какова текущая цена акций Rafarma Pharmaceuticals Inc (RAFA)?
По последним данным, цена акций Rafarma Pharmaceuticals Inc составляет 0,02 $, предыдущее закрытие — 0,01 $. За последнюю торговую сессию акции Rafarma Pharmaceuticals Inc выросли на 0,00 $, что соответствует росту на 28,57%.
Выплачивает ли Rafarma Pharmaceuticals Inc (RAFA) дивиденды?
Нет, Rafarma Pharmaceuticals Inc не выплачивает дивиденды.
Какой бета-коэффициент (волатильность) у Rafarma Pharmaceuticals Inc (RAFA)?
У компании Rafarma Pharmaceuticals Inc бета 0.591, что указывает на более низкую волатильность по сравнению с рынком в целом.
